6 May 2021
LIPAC Oncology Announces Appointment of Josh Hamermesh to the Board of Directors
Author: admintech | Filed under: Press ReleaseMENLO PARK, Calif., May 6, 2021 /PRNewswire/ — LIPAC Oncology LLC., a pharmaceutical company utilizing its liposome-bound nano-technology platform to provide precision targeted cancer drugs for the treatment of multiple tumor types, today announced the appointment of Josh Hamermesh as an…